M&A Deal Summary |
|
|---|---|
| Date | 2016-06-01 |
| Target | MTG Medical Technology Vertriebs- |
| Sector | Medical Products |
| Buyer(s) | Vitrolife |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Life Science |
| Employees | 1,115 |
| Revenue | 3.5B SEK (2023) |
Vitrolife is a producer and developer of products and systems for assisted reproduction worldwide. It offers fertility products, including follicle aspiration needles, paraffin oil under the OVOIL brand, additional media for in vitro fertilization (IVF) procedures, labware products, vitrification products, and Primo Vision time-lapse embryo monitoring systems. Vitrolife was founded in 1994 and is based in Gothenburg, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 7 |
| Sector (Medical Products) | 5 of 5 |
| Type (Add-on Acquisition) | 5 of 7 |
| Country (Germany) | 2 of 2 |
| Year (2016) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-01 |
OCTAX Microscience
Bruckberg, Germany OCTAX Microscience GmbH is a developer and producer of OCTAX laser and imaging systems. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-08 |
Igenomix
Valencia, Spain Igenomix engages in women’s health and reproductive genetic testing services for IVF clinics. The Company support c. 90,000 couples per year with a global footprint of 19 laboratories covering +80 countries. Igenomix was founded in 2011 and headquartered in Valencia, Spain. |
Buy | €1.3B |
